BioSpace News Archive

Press Releases

Sumitomo Pharma America Presents New Data on Nuvisertib and Enzomenib at the 2024 American Society of Hematology Annual Meeting

December 9, 2024
·
9 min read
Press Releases

Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer

December 9, 2024
·
6 min read
Press Releases

Opna Bio Announces Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis

December 9, 2024
·
4 min read
Press Releases

Scryb Launches New AI Governance Technology Business Unit, ‘Raidian’

December 9, 2024
·
4 min read
Press Releases

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

December 9, 2024
·
7 min read
Press Releases

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

December 9, 2024
·
2 min read
Press Releases

Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting

December 9, 2024
·
8 min read
Press Releases

Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting

December 9, 2024
·
10 min read
Press Releases

Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024

December 9, 2024
·
6 min read
Press Releases

MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting

December 9, 2024
·
5 min read